Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Icatibant in Patients With Bradykinin Induced Angioedema [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the safety and efficacy of icatibant in patients with bradykinin-mediated angioedema and hereditary angioedema has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bradykinin-mediated Angioedema
• Hereditary Angioedema

Drugs mentioned

• ICATIBANT (icatibant)

Snippet

Sponsor: Nang Kuang Pharmaceutical Co., Ltd. | Conditions: Bradykinin-mediated Angioedema, Hereditary Angioedema (HAE) | Phase 4 | Status: COMPLETED